India's pharmaceutical, biotechnology, and life sciences sector is one of the fastest-growing industries globally, fueled by an expanding domestic market.

Despite facing challenges such as regulatory hurdles, a shortage of skilled workers, high research and development costs, and intellectual property issues, the sector is poised for growth. Government support, strategic policy interventions, and the encouragement of foreign direct investment (FDI) are expected to stimulate further development in this dynamic industry. 

Union Budget 2025-26

Explore in-depth analysis and impact of announcements on business, industry and ecosystems

Know more
Image

The Grant Thornton Bharat advantage

  • Advisory on a global level
  • Practical experience
  • Sector knowledge
  • Advisory on a global level
    sales-strategy.png
    Our private healthcare advisory teams operate on a global level and offer insights and practical guidance in the UK and internationally.
  • Practical experience
    Practical experience
    We have years of practical industry experience, which guarantees our understanding of the distinctive aspects that characterise your market.
  • Sector knowledge
    Sector knowledge
    Our technical expertise spans across the entire sector, from primary and secondary care providers to medical device companies, retail healthcare providers, and healthcare distributors.

AI and life sciences: Navigating risks and challenges

As AI continues to transform other sectors, the life sciences industry has only recently begun to realize its full potential.

    Indian multinational pharmaceutical company

    Indian multinational pharmaceutical company

    1.
    Problem statement
    The client wanted to examine and review annual GST compliances to identify any non-compliances, process gaps, and scope for improvement.
    2.
    Our Solution
    We reviewed the client's compliance processes to identify lapses in procedures, positions, and documentation. We implemented controls to prevent the misuse of input tax credits (ITC) across states and to ensure timely issuance of credit...
    3.
    Impact
    The efficiency of the client’s compliance process improved, building tax efficiency in their entities and reducing the cost borne by them due to non-compliance and lapses in the process.
    Orange Background

    Assisting a pharmaceutical company with respect to...

    1.
    Problem statement
    While performing their day-to-day compliances under the erstwhile indirect tax regime and later on with the advent of Goods and Services Tax (GST) law w.e.f. 1 July 2017, a fortune 500 pharmaceutical company was looking for a one-point...
    2.
    Our Solution
    Our experts initially guided the client through comprehensive compliances under the previous tax regime, improving their complex data collation processes, and later expanded our role to include assessments and litigation support. With the...
    3.
    Impact
    The client was able to streamline their ERP and IT systems, enabling a hassle-free process of filing GST returns and issuance of e-invoices under GST. Further, our prompt proposition led to the successful closure of numerous litigations...
    Data architect and modelling to enable the Blackline implementation programme for a global pharma organisation

    Data architect and modelling to enable the Blackline...

    1.
    Problem statement
    The client, as part of their growth strategy, was executing a large finance transformation (FT) programme with multiple initiatives. In this regard, they wanted expertise in data architecture with profiling and modelling capabilities to...
    2.
    Our Solution
    Our team quickly began working on the transformation programme which was mid-way. Engagement was initiated with global stakeholder groups to identify the modelling requirements for open item matching and balance sheet quality. Our project...
    3.
    Impact
    In 12 Months, our team delivered the engagement expectation along with a detailed reusable data model for balance sheet reconciliation, improving accuracy and efficiency. The data model to capture the difference in volume between FI and...